BOOK
SPEC - Diagnostic Atlas of Renal Pathology E-Book 12 Month Subscrition
Agnes B. Fogo | Michael Kashgarian
(2011)
Additional Information
Book Details
Abstract
Diagnostic Atlas of Renal Pathology, by Agnes B. Fogo, MD and Michael Kashgarian, MD, delivers practical, highly visual guidance for effectively and accurately diagnosing a wide range of pathologic entities. More than 700 high-quality illustrations help you to recognize the pathologic features and clinical manifestations of both common and rare renal disorders and to formulate confident and accurate diagnoses. Thoroughly updated throughout, this companion to Brenner & Rector’s The Kidney, 9th Edition provides the newest information regarding categorizing and classification of diseases and describes how this relates to the various morphological lesions illustrated and their clinical significance.
- See more than 700 high quality representative images of light, immunofluorescence, and electron microscopy for each diagnostic entity with correlations to clinical presentation and pathogenesis.
- Easily locate in-depth information on any disease's clinical course and treatment by cross-referring companion text, Brenner & Rector’s The Kidney.
- Grasp key characteristic pathologic findings and prognostic, pathogenetic, and etiologic information through focused, detailed discussions.
- Make accurate, complete reports by fully understanding clinical correlations.
- Get an in-depth examination of pathophysiology, clinical presentations, and comprehensive references
- Keep current with the latest knowledge and evidence-based practices. Comprehensive updates throughout include a brand-new chapter on "Approaches to Chronic Kidney Disease" that includes coverage of Chronic Kidney Disease; Age-Related Sclerosis; Glomerular vs. Tubulointerstitial vs. Vascular Disease; and the differential diagnostic approach to Segmental Glomerulosclerosis lesions. Extensive updates to all previous chapters include new classifications of various diseases such as igA nephropathy, diabetic nephropathy, crescentic GN, and renal transplant rejection.
- Stay well informed about hot topics including acute phosphate nephropathy; new concepts in the pathogenesis of thrombotic microangiopathies and eclampsia; and new information relative to etiology and pathogenesis of podocytopathies.
- Quickly access the information you need thanks to a user-friendly format, tables and sidebars with key points and differential diagnoses, and chapters that include concise, templated discussions regarding the etiology and pathogenesis of the disorder.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front cover | cover | ||
Inside front cover | ifc1 | ||
Diagnostic Atlas of Renal Pathology, 2/e | i | ||
Copyright | ii | ||
Preface | iii | ||
Acknowledgments | v | ||
Table of Contents | vii | ||
1 Glomerular Diseases | 1 | ||
Normal Growth and Maturation | 2 | ||
Selected Reading | 10 | ||
Primary Glomerular Diseases | 11 | ||
Glomerular Diseases That Cause Nephrotic Syndrome: Non–Immune Complex | 11 | ||
Minimal Change Disease and Focal Segmental Glomerulosclerosis: Introduction | 11 | ||
Minimal Change Disease | 12 | ||
Selected Reading | 16 | ||
Focal Segmental Glomerulosclerosis | 16 | ||
Diagnosis of Recurrence of FSGS in the Transplant | 24 | ||
Differential Diagnosis of MCD vs. FSGS | 26 | ||
Etiology/Pathogenesis | 26 | ||
Selected Reading | 27 | ||
General | 27 | ||
Genetics | 28 | ||
Collapsing Glomerulopathy | 28 | ||
Etiology/Pathogenesis | 32 | ||
Selected Reading | 34 | ||
Tip Lesion Variant of FSGS | 35 | ||
Etiology/Pathogenesis | 37 | ||
Selected Reading | 37 | ||
Cellular Variant of FSGS | 37 | ||
Etiology/Pathogenesis | 38 | ||
Selected Reading | 38 | ||
Perihilar Variant of FSGS | 39 | ||
Etiology/Pathogenesis—Secondary Forms of FSGS | 39 | ||
Selected Reading | 41 | ||
Congenital Nephrotic Syndrome of Finnish Type | 42 | ||
Etiology/Pathogenesis | 42 | ||
Selected Reading | 45 | ||
Diffuse Mesangial Sclerosis | 45 | ||
Frasier Syndrome | 45 | ||
Etiology/Pathogenesis | 46 | ||
Selected Reading | 50 | ||
Glomerular Diseases That Cause Nephrotic/Nephritic Syndrome: Complement Related | 50 | ||
C1q Nephropathy | 50 | ||
Etiology/Pathogenesis | 52 | ||
Selected Reading | 53 | ||
Dense Deposit Disease | 53 | ||
Etiology/Pathogenesis | 55 | ||
Selected Reading | 60 | ||
C3 Glomerulonephritis | 61 | ||
Etiology/Pathogenesis | 61 | ||
Selected Reading | 65 | ||
Glomerular Diseases That Cause Nephrotic Syndrome: Immune Complex | 65 | ||
Membranous Nephropathy | 65 | ||
Etiology/Pathogenesis | 78 | ||
Selected Reading | 79 | ||
Membranoproliferative Glomerulonephritis, Type I | 80 | ||
Etiology/Pathogenesis | 88 | ||
Selected Reading | 93 | ||
Fibrillary Glomerulonephritis | 94 | ||
Etiology/Pathogenesis | 101 | ||
Selected Reading | 101 | ||
Immunotactoid Glomerulopathy | 102 | ||
Etiology/Pathogenesis | 104 | ||
Selected Reading | 106 | ||
Glomerular Diseases That Cause Hematuria or Nephritic Syndrome: Immune Complex | 107 | ||
Acute Postinfectious Glomerulonephritis | 107 | ||
Etiology/Pathogenesis | 115 | ||
Selected Reading | 117 | ||
IgA Nephropathy | 118 | ||
Etiology/Pathogenesis | 128 | ||
Selected Reading | 131 | ||
Secondary Glomerular Diseases | 132 | ||
Diseases Associated with Nephrotic Syndrome | 132 | ||
Monoclonal Immunoglobulin Deposition Disease | 132 | ||
Amyloidosis | 133 | ||
Etiology/Pathogenesis | 141 | ||
Light Chain Deposition Disease | 142 | ||
Light and Heavy Chain Deposition Disease and Heavy Chain Deposition Disease | 151 | ||
Etiology/Pathogenesis of MIDD | 154 | ||
Selected Reading | 158 | ||
Amyloidosis | 158 | ||
LCDD, LHCDD, and HCDD | 159 | ||
Proliferative Glomerulonephritis with Monoclonal Deposits | 159 | ||
Etiology/Pathogenesis | 162 | ||
Selected Reading | 163 | ||
HIV-Associated Nephropathy | 163 | ||
Etiology/Pathogenesis | 166 | ||
Selected Reading | 169 | ||
Sickle Cell Nephropathy | 170 | ||
Etiology/Pathogenesis | 175 | ||
Selected Reading | 176 | ||
Fabry Disease | 177 | ||
Etiology/Pathogenesis | 180 | ||
Selected Reading | 182 | ||
Lipoprotein Glomerulopathy | 183 | ||
Selected Reading | 185 | ||
Lecithin-Cholesterol Acyltransferase Deficiency | 185 | ||
Etiology/Pathogenesis | 188 | ||
Selected Reading | 188 | ||
Hereditary Focal Segmental Glomerulosclerosis | 189 | ||
Selected Reading | 190 | ||
Diseases Associated with Nephritic Syndrome or RPGN: Immune Mediated | 190 | ||
Lupus Nephritis | 190 | ||
Histopathology | 194 | ||
Class I Minimal Mesangial Lupus Nephritis | 194 | ||
Class II Mesangial Proliferative Lupus Nephritis | 195 | ||
Class III Focal Lupus Nephritis | 195 | ||
Class IV Diffuse Lupus Nephritis | 198 | ||
Class V Membranous Lupus Nephritis | 202 | ||
Class VI Advanced Sclerosing Lupus Nephritis | 203 | ||
Atypical Presentations of Renal Involvement in SLE | 212 | ||
Lupus Podocytopathy/Minimal Change Disease | 212 | ||
ANCA-Associated Nephritis | 214 | ||
Mixed Patterns and Transformation | 214 | ||
Immunofluorescence Microscopic Features | 215 | ||
Additional Pathologic Features | 218 | ||
Vascular Lesions | 218 | ||
Tubulointerstitial Disease | 220 | ||
Assessment of Severity and Chronicity | 221 | ||
Etiology/Pathogenesis | 222 | ||
Selected Reading | 223 | ||
Henoch–Schönlein Purpura | 223 | ||
Etiology/Pathogenesis | 232 | ||
Selected Reading | 232 | ||
Mixed Connective Tissue Disease | 233 | ||
Etiology/Pathogenesis | 233 | ||
Selected Reading | 241 | ||
Mixed Cryoglobulinemia | 241 | ||
Etiology/Pathogenesis | 249 | ||
Selected Reading | 252 | ||
Anti-GBM Antibody–Mediated Glomerulonephritis | 252 | ||
Etiology/Pathogenesis | 256 | ||
Selected Reading | 260 | ||
Diseases Associated with the Nephritic Syndrome or RPGN: Pauci-Immune- or Non-Immune-Mediated | 260 | ||
Introduction | 260 | ||
Granulomatosis with Polyangiitis (Wegener)/Microscopic Polyangiitis | 262 | ||
Etiology/Pathogenesis | 267 | ||
Selected Reading | 271 | ||
Polyarteritis Nodosa | 271 | ||
2 Vascular Diseases | 303 | ||
Diabetic Nephropathy | 303 | ||
Etiology/Pathogenesis | 314 | ||
Selected Reading | 315 | ||
Thrombotic Microangiopathy/Thrombotic Thrombocytopenic Purpura | 315 | ||
Etiology/Pathogenesis | 328 | ||
Selected Reading | 329 | ||
Scleroderma (Progressive Systemic Sclerosis) | 330 | ||
Etiology/Pathogenesis | 336 | ||
Selected Reading | 337 | ||
Antiphospholipid Antibody Disease | 338 | ||
Etiology/Pathogenesis | 338 | ||
Selected Reading | 338 | ||
Preeclampsia and Eclampsia | 338 | ||
Pathology | 339 | ||
Etiology/Pathogenesis | 339 | ||
Selected Reading | 348 | ||
Fibromuscular Dysplasia | 348 | ||
Etiology/Pathogenesis | 349 | ||
Pathology | 349 | ||
Selected Reading | 353 | ||
Arterionephrosclerosis | 353 | ||
Etiology/Pathogenesis | 361 | ||
Selected Reading | 363 | ||
Accelerated/Malignant Hypertension | 364 | ||
Etiology/Pathogenesis | 368 | ||
Selected Reading | 369 | ||
Atheroemboli | 369 | ||
Etiology/Pathogenesis | 373 | ||
Selected Reading | 374 | ||
3 Tubulointerstitial Diseases | 377 | ||
Introduction | 377 | ||
Acute Pyelonephritis | 379 | ||
Etiology/Pathogenesis | 380 | ||
Selected Reading | 385 | ||
Chronic Pyelonephritis and Reflux Nephropathy | 385 | ||
4 Chronic Kidney Disease | 465 | ||
Introduction | 465 | ||
Age-Related Sclerosis | 465 | ||
Selected Reading | 468 | ||
Glomerular vs. Tubulointerstitial vs. Vascular Disease | 469 | ||
Selected Reading | 469 | ||
Segmental Glomerulosclerosis: Primary vs. Secondary | 470 | ||
Selected Reading | 471 | ||
5 Renal Transplantation | 473 | ||
Introduction | 473 | ||
Etiology/Pathogenesis | 475 | ||
Antibody-Mediated Rejection | 475 | ||
Chronic Active Antibody-Mediated Rejection and Transplant Glomerulopathy | 478 | ||
Acute T Cell–Mediated Rejection | 479 | ||
Borderline Changes: “Suspicious for Acute Rejection” | 480 | ||
Banff Type I Acute Rejection | 480 | ||
Banff Type II Acute Rejection | 482 | ||
Banff Type III Acute Rejection | 483 | ||
Chronic Allograft Failure (Chronic Allograft Nephropathy) | 485 | ||
Cyclosporin/FK506 Nephrotoxicity | 486 | ||
Etiology/Pathogenesis | 488 | ||
Posttransplant Lymphoproliferative Disease | 488 | ||
Etiology/pathogenesis | 491 | ||
Selected Reading | 491 | ||
Viral Infections | 491 | ||
Selected Reading | 497 | ||
6 Cystic Diseases of the Kidney | 499 | ||
Introduction | 499 | ||
Autosomal Dominant Polycystic Kidney Disease | 499 | ||
Pathology | 499 | ||
Autosomal Recessive Polycystic Kidney Disease | 504 | ||
Pathology | 505 | ||
Medullary Cystic Disease/Nephronophthisis | 506 | ||
Medullary Sponge Kidney | 508 | ||
Etiology/Pathogenesis | 510 | ||
Selected Reading | 511 | ||
Acquired Cystic Disease | 511 | ||
Selected Reading | 513 | ||
Cystic Renal Dysplasia | 513 | ||
Etiology/Pathogenesis | 516 | ||
Selected Reading | 516 | ||
7 Renal Neoplasia | 517 | ||
Introduction | 517 | ||
Renal Cell Carcinomas | 517 | ||
Other Renal Epithelial Tumors | 519 | ||
Etiology/Pathogenesis | 519 | ||
Selected Reading | 529 | ||
Wilms Tumor | 529 | ||
Etiology/Pathogenesis | 532 | ||
Selected Reading | 533 | ||
Transitional Cell Carcinoma of the Renal Pelvis | 533 | ||
Etiology/Pathogenesis | 534 | ||
Selected Reading | 534 | ||
Index | 535 | ||
A | 535 | ||
B | 536 | ||
C | 536 | ||
D | 538 | ||
E | 538 | ||
F | 538 | ||
G | 539 | ||
H | 540 | ||
I | 541 | ||
J | 542 | ||
K | 542 | ||
L | 543 | ||
M | 543 | ||
N | 545 | ||
O | 545 | ||
P | 545 | ||
R | 547 | ||
S | 548 | ||
T | 549 | ||
U | 550 | ||
V | 550 | ||
W | 550 | ||
X | 550 |